关注
sara e jones
sara e jones
在 iu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors
SE Jones, J Versalovic
BMC microbiology 9 (1), 35, 2009
5752009
Protection from intestinal inflammation by bacterial exopolysaccharides
SE Jones, ML Paynich, DB Kearns, KL Knight
The Journal of Immunology 192 (10), 4813-4820, 2014
1172014
Exopolysaccharide from Bacillus subtilis Induces Anti-Inflammatory M2 Macrophages That Prevent T Cell–Mediated Disease
ML Paynich, SE Jones-Burrage, KL Knight
The Journal of Immunology, 1601641, 2017
922017
Analysis of bacterial communities during Clostridium difficile infection in the mouse
EG Semenyuk, VA Poroyko, PF Johnston, SE Jones, KL Knight, ...
Infection and immunity 83 (11), 4383-4391, 2015
832015
FolC2‐mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri
CM Thomas, D Saulnier, JK Spinler, P Hemarajata, C Gao, SE Jones, ...
MicrobiologyOpen 5 (5), 802-818, 2016
532016
Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella
SE Jones, KL Knight
Infection and immunity 80 (2), 710-719, 2012
402012
Identification of Lactobacillus strains with probiotic features from the bottlenose dolphin (Tursiops truncatus)
MA Diaz, EM Bik, KP Carlin, SK Venn‐Watson, ED Jensen, SE Jones, ...
Journal of applied microbiology 115 (4), 1037-1051, 2013
372013
Cell Aggregation and Aerobic Respiration Are Important for Zymomonas mobilis ZM4 Survival in an Aerobic Minimal Medium
SE Jones-Burrage, TA Kremer, JB McKinlay
Applied and Environmental Microbiology 85 (10), e00193-19, 2019
282019
Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition
SE Jones, K Whitehead, D Saulnier, CM Thomas, J Versalovic, RA Britton
Gut microbes 2 (2), 69-79, 2011
282011
Pantothenate auxotrophy in Zymomonas mobilis ZM4 is due to a lack of aspartate decarboxylase activity
JR Gliessman, TA Kremer, AA Sangani, SE Jones-Burrage, JB McKinlay
FEMS microbiology letters 364 (13), fnx136, 2017
112017
Exopolysaccharides: Sweet success with probiotic therapeutics
SE Jones, ML Paynich, KL Knight
Inflammation and Cell Signaling 1 (3), 2014
112014
Commensal exopolysaccharides induce M2 macrophages that prevent pathogen-induced colitis
ML Paynich, SE Jones, KL Knight
The Journal of Immunology 196 (1 Supplement), 131.3-131.3, 2016
22016
Exopolysaccharide for inflammatory disease
B Osborne, F Ayaz, K Knight, S Jones
US Patent App. 15/095,604, 2016
22016
Genetics and functional genomics of probiotic bacteria: translation to applications
SE Jones, J Versalovic
Functional dairy products, 338, 2007
22007
Genetics and functional genomics of probiotic bacteria
SE Jones, J Versalovic
Elsevier, Ltd., 2007
22007
Identification of Chikungunya virus nucleocapsid core assembly modulators
SE Jones-Burrage, Z Tan, L Li, A Zlotnick, S Mukhopadhyay
bioRxiv, 774943, 2019
12019
Cell aggregation and aerobic respiration facilitate survival of Zymomonas mobilis ZM4 in an aerobic minimal medium
SE Jones-Burrage, TA Kremer, JB McKinlay
bioRxiv, 526699, 2019
2019
FolC2-m ediatedfolatemetabolismcontributestosuppression ofinflammationbyprobioticLactobacillus reuteri
CM Thomas, DMA Saulnier, JK Spinler, P Hemarajata, C Gao, SE Jones, ...
2016
Mechanism by which commensal exopolysaccharides limit inflammation (MUC9P. 744)
M Paynich, S Jones, K Knight
The Journal of Immunology 194 (1 Supplement), 205.8-205.8, 2015
2015
Dependency of TLR4 signaling for the anti-inflammatory effect of exopolysaccharide (EPS) of Bacillus subtilis (MPF4P. 731)
S Jones, M Paynich, K Knight
The Journal of Immunology 194 (1 Supplement), 136.7-136.7, 2015
2015
系统目前无法执行此操作,请稍后再试。
文章 1–20